New Migraine Patch submitted for approval by FDA
BioPharmaceutical company Nupathe Inc said that its new drug application NP101had been accepted for filing by the US Food and Drug administrator. If accepted and approved, the patch will be the first transdermal type delivery system for Migraine sufferers. It is hoped the product will be ready for release by presricption in 2013.
http://www.rttnews.com/1935391/nupathe-s-nda-resubmission-for-migraine-patch-accepted-by-fda.aspx?type=qf&;utm_source=google&utm_campaign=sitemap
